Subversion of lysosomal trafficking by HHV-7 U21

HHV-7 U21 颠覆溶酶体贩运

基本信息

  • 批准号:
    9706283
  • 负责人:
  • 金额:
    $ 12.65万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-09-01 至 2020-07-31
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY/ABSTRACT. The goal of this administrative supplement request is to provide a state-of-the- art microscope for cell biological studies of lysosomal sorting for R01GM120735. The requested instrument will be shared equally with Drs. Blake Hill (R01GM067180.) and Matt Scaglione (R35GM119544) for their cell biological studies in mitochondria fission and proteostasis, respectively. The herpesviruses have co-evolved with their hosts for hundreds of millions of years. As our adaptive immune systems evolved, so did the mechanisms of immune evasion encoded by herpesviruses. Because herpesviruses remain latent or persistent within their host throughout life, the herpesviruses have evolved a unique set of strategies to help them contend with the lifelong host immune response. This application’s central premise is that the herpesviruses, in their evolution, have performed a 100 million-year-long genetic screen to undermine host defense mechanisms, and in so doing, can illuminate cell biological processes that we may not yet understand; we seek to take advantage of their evolution to discover new concepts in cell biology. The long term goal of this project is to understand the underlying cell biological mechanisms by which human herpesviruses-6 and -7 (HHV-6/7) escape host defense mechanisms. The focus of this proposal is to understand how HHV-7 U21 reroutes class I MHC molecules to lysosomes, and in so doing, understand the cellular pathway usurped by U21. Our preliminary data indicate that U21 employs an unknown sorting mechanism that seems to defy convention - almost certainly utilizing a novel cellular means of lysosomal sorting. In Aim 1, we assess the structure and association of U21 with itself, as a homotetramers, and determine whether homooligomerization of U21 is necessary its ability to bind to and reroute class I MHC molecules to lysosomes, and use RUSH to examine the synchronous trafficking of U21 and class I molecules to lysosomes. We ultimately seek a temporal and mechanistic view of how U21 undermines the cellular lysosomal trafficking pathway, and how this lysosomal trafficking pathway functions in the absence of U21. A better understanding of this process should contribute to our understanding of basic underlying principles of lysosomal trafficking, and also lead to a more thorough comprehension of how these viruses have such great success in evading the host immune response.
项目总结/抽象。此管理补充请求的目标是提供-的状态

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AMY W HUDSON其他文献

AMY W HUDSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AMY W HUDSON', 18)}}的其他基金

Immune evasion in a humanized mouse model of HHV-6 infection
HHV-6 感染人源化小鼠模型中的免疫逃避
  • 批准号:
    8500953
  • 财政年份:
    2013
  • 资助金额:
    $ 12.65万
  • 项目类别:
Discovery of novel immunoevasins from HHV-6 and -7
从 HHV-6 和 -7 中发现新型免疫逃避蛋白
  • 批准号:
    7359231
  • 财政年份:
    2008
  • 资助金额:
    $ 12.65万
  • 项目类别:
Discovery of novel immunoevasins from HHV-6 and -7
从 HHV-6 和 -7 中发现新型免疫逃避蛋白
  • 批准号:
    7644445
  • 财政年份:
    2008
  • 资助金额:
    $ 12.65万
  • 项目类别:
Mechanisms of immune evasion by HHV-6 and HHV-7 U21
HHV-6 和 HHV-7 U21 的免疫逃避机制
  • 批准号:
    7319325
  • 财政年份:
    2007
  • 资助金额:
    $ 12.65万
  • 项目类别:
Mechanisms of immune evasion by HHV-6 and HHV-7 U21
HHV-6 和 HHV-7 U21 的免疫逃避机制
  • 批准号:
    8092661
  • 财政年份:
    2007
  • 资助金额:
    $ 12.65万
  • 项目类别:
Mechanisms of immune evasion by HHV-6 and HHV-7 U21
HHV-6 和 HHV-7 U21 的免疫逃避机制
  • 批准号:
    7898957
  • 财政年份:
    2007
  • 资助金额:
    $ 12.65万
  • 项目类别:
Mechanisms of immune evasion by HHV-6 and HHV-7 U21
HHV-6 和 HHV-7 U21 的免疫逃避机制
  • 批准号:
    7646378
  • 财政年份:
    2007
  • 资助金额:
    $ 12.65万
  • 项目类别:
Mechanisms of immune evasion by HHV-6 and HHV-7 U21
HHV-6 和 HHV-7 U21 的免疫逃避机制
  • 批准号:
    7448432
  • 财政年份:
    2007
  • 资助金额:
    $ 12.65万
  • 项目类别:
MOLECULAR BASIS OF SYNAPTIC VESICLE FORMATION
突触小泡形成的分子基础
  • 批准号:
    2875941
  • 财政年份:
    1998
  • 资助金额:
    $ 12.65万
  • 项目类别:
MOLECULAR BASIS OF SYNAPTIC VESICLE FORMATION
突触小泡形成的分子基础
  • 批准号:
    2774511
  • 财政年份:
    1997
  • 资助金额:
    $ 12.65万
  • 项目类别:

相似海外基金

A Longitudinal Qualitative Study of Fentanyl-Stimulant Polysubstance Use Among People Experiencing Homelessness (Administrative supplement)
无家可归者使用芬太尼兴奋剂多物质的纵向定性研究(行政补充)
  • 批准号:
    10841820
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Proton-secreting epithelial cells as key modulators of epididymal mucosal immunity - Administrative Supplement
质子分泌上皮细胞作为附睾粘膜免疫的关键调节剂 - 行政补充
  • 批准号:
    10833895
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Administrative Supplement: Life-Space and Activity Digital Markers for Detection of Cognitive Decline in Community-Dwelling Older Adults: The RAMS Study
行政补充:用于检测社区老年人认知衰退的生活空间和活动数字标记:RAMS 研究
  • 批准号:
    10844667
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
StrokeNet Administrative Supplement for the Funding Extension
StrokeNet 资助延期行政补充文件
  • 批准号:
    10850135
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
  • 批准号:
    10896844
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Biomarkers of Disease in Alcoholic Hepatitis Administrative Supplement
酒精性肝炎行政补充剂中疾病的生物标志物
  • 批准号:
    10840220
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Administrative Supplement: Improving Inference of Genetic Architecture and Selection with African Genomes
行政补充:利用非洲基因组改进遗传结构的推断和选择
  • 批准号:
    10891050
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Power-Up Study Administrative Supplement to Promote Diversity
促进多元化的 Power-Up 研究行政补充
  • 批准号:
    10711717
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Administrative Supplement for Peer-Delivered and Technology-Assisted Integrated Illness Management and Recovery
同行交付和技术辅助的综合疾病管理和康复的行政补充
  • 批准号:
    10811292
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
Sedentary behavior, physical activity, and 24-hour behavior in pregnancy and offspring health: the Pregnancy 24/7 Offspring Study Administrative Supplement
久坐行为、体力活动和 24 小时行为对怀孕和后代健康的影响:怀孕 24/7 后代研究行政补充
  • 批准号:
    10893074
  • 财政年份:
    2023
  • 资助金额:
    $ 12.65万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了